Q 
Qatari German Company for Medical Devices QPSC QGMD.QA · QAR
Health Care · Qatar Stock Exchange · 🇶🇦 Qatar
1.29
—
Close of 9 Nov 2026, in QAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in QAR, from our data supplier.
Revenue
QAR 10.0m
FY2014FY2024
Net income
−QAR 68.5m
FY2014FY2024
Free cash flow
QAR 1.0m
FY2014FY2024
Shareholders' equity
−QAR 32.5m
FY2014FY2024
Income statement
Fiscal years
| FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | QAR 10.0m | QAR 27.9m | QAR 42.7m | QAR 40.6m | QAR 8.2m | QAR 11.4m | QAR 11.8m | QAR 12.7m | QAR 16.4m | QAR 15.8m |
| Operating income | −QAR 57.4m | QAR 2.0m | QAR 5.1m | QAR 6.2m | −QAR 6.8m | −QAR 8.8m | −QAR 11.0m | −QAR 7.1m | −QAR 7.7m | −QAR 9.7m |
| Net income | −QAR 68.5m | QAR 1.3m | QAR 1.2m | QAR 1.2m | −QAR 10.4m | −QAR 12.8m | −QAR 21.7m | −QAR 10.4m | −QAR 11.4m | −QAR 13.3m |
| Diluted earnings per share | -0.59 | 0.01 | 0.01 | 0.01 | -0.09 | -0.11 | -0.19 | -0.09 | -0.10 | -0.12 |
Balance sheet
At each fiscal year end
| FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | QAR 143.9m | QAR 200.9m | QAR 194.1m | QAR 187.5m | QAR 154.1m | QAR 162.3m | QAR 171.0m | QAR 188.8m | QAR 194.9m | QAR 192.1m |
| Cash and short-term investments | QAR 524,000 | QAR 119,900 | QAR 6.3m | QAR 5.2m | QAR 961,900 | QAR 494,100 | QAR 541,100 | QAR 952,100 | QAR 741,100 | QAR 148,700 |
| Total liabilities | QAR 176.3m | QAR 164.9m | QAR 159.6m | QAR 154.9m | QAR 123.5m | QAR 121.3m | QAR 117.1m | QAR 113.3m | QAR 109.0m | QAR 94.7m |
| Debt | QAR 151.7m | QAR 142.4m | QAR 144.9m | QAR 142.1m | QAR 120.0m | QAR 117.7m | QAR 112.1m | QAR 107.6m | QAR 103.1m | QAR 86.5m |
| Shareholders' equity | −QAR 32.5m | QAR 36.0m | QAR 34.5m | QAR 32.7m | QAR 30.6m | QAR 41.0m | QAR 53.9m | QAR 75.6m | QAR 85.9m | QAR 97.4m |
| Shares outstanding | 116m | 116m | 116m | 116m | 116m | 116m | 116m | 116m | 116m | 116m |
Cash flow
Fiscal years
| FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | QAR 1.1m | −QAR 975,300 | QAR 1.0m | QAR 5.8m | QAR 1.9m | −QAR 1.3m | −QAR 1.2m | QAR 370,800 | −QAR 5.5m | −QAR 13.2m |
| Capital spending | −QAR 36,300 | −QAR 1.1m | −QAR 251,700 | −QAR 558,600 | −QAR 85,200 | −QAR 248,900 | — | −QAR 1.3m | −QAR 3.8m | −QAR 1.2m |
| Free cash flow | QAR 1.0m | −QAR 2.0m | QAR 795,800 | QAR 5.2m | QAR 1.8m | −QAR 1.6m | −QAR 1.2m | −QAR 960,500 | −QAR 9.3m | −QAR 14.4m |
Latest quarters
By quarter end
| Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | QAR 654,400 | QAR 1.1m | QAR 717,900 | QAR 1.7m | QAR 1.6m | QAR 5.9m | QAR 2.6m | QAR 236,300 |
| Operating income | −QAR 925,100 | −QAR 1.4m | −QAR 57.3m | −QAR 1.5m | QAR 798,300 | QAR 567,000 | −QAR 801,800 | −QAR 1.2m |
| Net income | QAR 7.4m | −QAR 1.6m | −QAR 67.7m | −QAR 1.7m | QAR 577,400 | QAR 284,500 | QAR 1.2m | −QAR 1.4m |
| Diluted earnings per share | 0.06 | -0.01 | -0.59 | -0.01 | 0.01 | 0.00 | 0.01 | -0.01 |
| Total assets | QAR 139.7m | QAR 141.3m | QAR 143.9m | QAR 199.0m | QAR 200.1m | QAR 200.8m | QAR 200.9m | QAR 199.5m |
| Cash and short-term investments | QAR 121,700 | QAR 211,400 | QAR 524,000 | QAR 797,700 | QAR 389,100 | QAR 199,300 | QAR 119,900 | QAR 110,900 |
| Debt | QAR 135.6m | QAR 13.7m | QAR 13.2m | QAR 11.9m | QAR 12.3m | QAR 10.6m | QAR 10.6m | QAR 130.4m |
| Shareholders' equity | −QAR 26.7m | −QAR 34.0m | −QAR 32.5m | QAR 35.2m | QAR 36.9m | QAR 36.3m | QAR 36.0m | QAR 34.7m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -37.3% | -2.6% | -1.3% |
| Operating income | — | 45.5% | 20.1% |
| Net income | — | 39.8% | 24.1% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -146.5% | -36.5% | -42.5% | -50.0% |
| Net margin | -177.5% | -53.5% | -62.5% | -73.1% |
Valuation history
At each fiscal year end
| FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -2.3 | 125.4 | 116.7 | 311.1 | -6.5 | -5.1 | -3.4 | -11.2 | -13.9 | -8.8 |
| Price to sales | 15.8 | 6.0 | 3.4 | 9.1 | 8.2 | 5.7 | 6.3 | 9.2 | 9.7 | 7.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 8 Apr 2009.
| FY2009 | |
|---|---|
| Paid in the year | 0.005 |
- 10-for-1 split · 19 Jun 2019
- 21-for-20 split · 25 May 2006
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.